Coave Therapeutics: redecorating viral vectors for improved gene therapies Coave Therapeutics is a French biotech developing gene therapies for neurodegenerative and ocular diseases. The company has developed a technology […] January 25, 2023 · V-Bio Ventures
Brewing up a new business: AB InBev surprises with ambitions for animal-free proteins Belgian-American AB InBev, the world’s largest brewer, has set up a separate R&D division called BioBrew to develop animal-free proteins […] January 25, 2023 · BioVox
Energizing the transition: ACROBAT consortium devises smart and sustainable ways to recycle LFP batteries Batteries are a crucial component of the energy transition away from fossil fuels, but the technology currently faces issues with […] January 25, 2023 · BioVox
The chaos of choice: how do people pick their food products? Every family needs groceries, and most people regularly venture to the supermarket to gather supplies. If researchers can help shoppers […] January 25, 2023 · SciMingo
Why diversity matters in management teams, and how to achieve it The biotech industry is suffering from a serious talent shortage, with start-ups in particular having an increasingly hard time filling […] December 14, 2022 · V-Bio Ventures
Stew before you chew – why the way you cook pulses makes a difference to your nutrition Do you look at the composition or caloric content of foods to make healthy choices? In healthy foods, not only […] December 14, 2022 · SciMingo
From multiple pills per day to one treatment per month: progress in HIV medication made possible by pharma collaborations Unprecedented collaborations between different pharmaceutical companies have resulted in extraordinary progress for HIV patients over the past four decades. From […] December 5, 2022 · Janssen Pharmaceutica
Data science in early drug discovery – getting it right from the start The application of data science in the early stages of drug development is not new – progress in algorithms and […] November 24, 2022 · Janssen Pharmaceutica
Cancer vaccines: not only treating tumors, but preventing them too The COVID-19 pandemic has brought vaccines back into the drug development spotlight, and mRNA vaccines are stealing the show with […] November 23, 2022 · V-Bio Ventures
New personalized cancer vaccine in the making thanks to unique Belgian collaboration The young Belgian start-up Persomed is unique – it was founded in 2020 by four partners each with relevant expertise […] November 23, 2022 · BioVox
Marfan patients team up with researchers to catch their silent killer The world’s undiagnosed Marfan patients often go through life unaware of the hidden killer lurking in their DNA – a […] November 23, 2022 · SciMingo
Gene therapy challenges and the solutions in sight Dr. Federico Mingozzi is the CSO of Spark Therapeutics, the company behind Luxturna – the world’s first FDA-approved gene therapy […] October 19, 2022 · BioVox
Picking up early signals: SPINOVIT to prevent cardiovascular diseases with new monitoring method Preventing cardiovascular diseases before the first symptoms arise? That’s the ambition of SPINOVIT – a Louvain-La-Neuve company using a new […] October 19, 2022 · BioVox
BioVox: shining a light on Belgian biotech Beer, chocolate, and… biotech! When it comes to life sciences, Belgium excels. It consistently ranks as one of the world’s […] October 19, 2022 · BioVox
From pattern to patient: microbiome research needs to bridge the gap to the clinic The microbiome has been a trending scientific topic in recent years. Researchers have uncovered correlations between the human microbiome and […] September 7, 2022 · BioVox